
0:00
NaN:NaN:NaN
A case in which the Court held that generic drug makers cannot be sued for not warning about potentially dangerous side effects on their drug labels, even when they follow federal rules that only require their labels to match those of their brand-name equivalents.
Weitere Episoden von „U.S. Supreme Court 2010 Term Arguments“



Verpasse keine Episode von “U.S. Supreme Court 2010 Term Arguments” und abonniere ihn in der kostenlosen GetPodcast App.








